Dr. Versha Banerji
@v_banerji
CLL clinician-scientist /Assoc.Prof U of M patient/health advocate. ✈️💣fan. wife, sports mom x 3 MD/FRCPs U of M, research post doc MIT/Harvard HBS WLF she/her
ID: 2847724307
28-10-2014 04:26:09
2,2K Tweet
933 Followers
1,1K Following
Today in Science Magazine, together with my former colleagues at NIBR, we report the discovery and characterization of first molecular glue degraders of the WIZ transcription factor (TF) for fetal hemoglobin derepression and therapeutic consideration in Sickle Cell Disease. 1/10
Thrilled to receive this support from Research Manitoba to study long-term microvascular injury and muscle weakness in our murine model of sepsis. Sepsis Canada Manoj Lalu Patricia Liaw Alison Fox-Robichaud, MD Braedon McDonald U of M Rady Faculty Physiology & Pathophysiology U of M
Informative and sobering dataset on CNS relapse of DLBCL from a large French-German collaboration just published in Leukemia Journal ~46% of pts with CNS relapse had a low CNS-IPI Most CNS relapses occur in the first year Still have a dismal prognosis nature.com/articles/s4137…
Today is #worldCLLday. I am grateful to serve #CLL community and bring the best care possible. I want to thank our partners University of Manitoba CancerCare Manitoba Research CancerCare Manitoba Foundation AstraZeneca Canada AbbVie Canada Janssen Canada Beigene Canada and LillyPad Canada and our clinical team CancerCare Manitoba
Enabling complex treatment to be delivered across our province and access to different types of treatment to allow for easier access to care based on a patients specific need. Thank you to CancerCare Manitoba to help us achieve our goals along with Manitoba Government Wab Kinew Uzoma Asagwara
Thank you Ontario Health OLMP, thank you Dynacare, thank you LifeLabs, thank you AlphaLabs, thank you University of Toronto, thank you to all members of ‘Raise the Bar’. This is a big step forward for Ontario and for 🇨🇦 Canada in promoting health equity for ppl with iron deficiency. 💥